These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26238454)

  • 21. Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation.
    Martinelli N; Baroni M; Castagna A; Lunghi B; Stefanoni F; Tosi F; Croce J; Udali S; Woodhams B; Girelli D; Bernardi F; Olivieri O
    Thromb Haemost; 2019 Feb; 119(2):192-202. PubMed ID: 30602199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of sex on renal function decline in people with Type 2 diabetes.
    de Hauteclocque A; Ragot S; Slaoui Y; Gand E; Miot A; Sosner P; Halimi JM; Zaoui P; Rigalleau V; Roussel R; Saulnier PJ; Hadjadj Samy S;
    Diabet Med; 2014 Sep; 31(9):1121-8. PubMed ID: 24773061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
    Barr ELM; Barzi F; Hughes JT; Jerums G; Hoy WE; O'Dea K; Jones GRD; Lawton PD; Brown ADH; Thomas M; Ekinci EI; Sinha A; Cass A; MacIsaac RJ; Maple-Brown LJ
    Diabetes Care; 2018 Apr; 41(4):739-747. PubMed ID: 29367427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis.
    Wyler von Ballmoos MC; Haring B; Sacks FM
    J Clin Lipidol; 2015; 9(4):498-510. PubMed ID: 26228667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of decreasing renal function on lipoprotein profiles.
    Attman PO; Samuelsson O; Alaupovic P
    Nephrol Dial Transplant; 2011 Aug; 26(8):2572-5. PubMed ID: 21220758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CHA
    Beyer-Westendorf J; Kreutz R; Posch F; Ay C
    Int J Cardiol; 2018 Feb; 253():71-77. PubMed ID: 29306476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans.
    Graham MJ; Lee RG; Bell TA; Fu W; Mullick AE; Alexander VJ; Singleton W; Viney N; Geary R; Su J; Baker BF; Burkey J; Crooke ST; Crooke RM
    Circ Res; 2013 May; 112(11):1479-90. PubMed ID: 23542898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.
    Nacak H; van Diepen M; Qureshi AR; Carrero JJ; Stijnen T; Dekker FW; Evans M
    Nephrol Dial Transplant; 2015 Dec; 30(12):2039-45. PubMed ID: 26185050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between dipstick hematuria and decline in estimated glomerular filtration rate among Japanese patients with type 2 diabetes: A prospective cohort study [Diabetes Distress and Care Registry at Tenri (DDCRT 14)].
    Mashitani T; Hayashino Y; Okamura S; Kitatani M; Furuya M; Iburi T; Tsujii S; Ishii H;
    J Diabetes Complications; 2017 Jul; 31(7):1079-1084. PubMed ID: 28499960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
    Chan DC; Chen MM; Ooi EM; Watts GF
    Int J Clin Pract; 2008 May; 62(5):799-809. PubMed ID: 18201179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state.
    Chan DC; Wong AT; Pang J; Barrett PH; Watts GF
    Clin Sci (Lond); 2015 Mar; 128(6):379-85. PubMed ID: 25291660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein-defined lipoprotein abnormalities in rheumatoid arthritis patients and their potential impact on cardiovascular disease.
    Knowlton N; Wages JA; Centola MB; Alaupovic P
    Scand J Rheumatol; 2012 May; 41(3):165-9. PubMed ID: 22401593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The kidney and cardiovascular outcome trials.
    Bloomgarden Z
    J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum lipoprotein(a) levels and diabetic nephropathy among Japanese patients with type 2 diabetes mellitus.
    Senba H; Furukawa S; Sakai T; Niiya T; Miyake T; Yamamoto S; Ueda T; Torisu M; Minami H; Miyaoka H; Onji M; Tanaka K; Matsuura B; Tanigawa T; Hiasa Y; Miyake Y
    J Diabetes Complications; 2016 Jul; 30(5):923-7. PubMed ID: 26947887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated atherogenic index and higher triglyceride increase risk of kidney function decline: a 7-year cohort study in Chinese adults.
    Huang F; Wang L; Zhang Q; Wan Z; Hu L; Xu R; Cheng A; Lv Y; Liu Q
    Ren Fail; 2021 Dec; 43(1):32-39. PubMed ID: 33307922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
    Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
    Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.